Minneapolis: A breakthrough cancer therapy that can wipe out leukemia in some deathly ill children and young adults comes with an expensive, long-lasting side effect. Novartis’s therapy commandeers the body’s immune system to destroy the cells where the blood cancer begins. That could create problems if demand surges because of Novartis’s cancer treatment. But the normal B cells are also being eliminated,” said Emory’s Waller. “It’s bad that it might be permanent.”Kite’s therapy also hurt the antibody-producing B cells, but they came back.

Source: Mint July 13, 2017 05:37 UTC